Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Fingolimod hydrochloride
Cat. No.:
OB0225LY-0081
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Fingolimod hydrochloride is an immunomodulator that acts on lymphocytes through selective homeostasis, preventing their migration from lymphoid organs to the central nervous system.
Synonym:
Fingolimod (FTY720) HCl; FTY720; 162359-56-0; Fingolimod HCl; FTY720; 2-Amino-2-(4-octylphenethyl)propane-1,3-diol hydrochloride; 2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride; 2-Amino-2-[2-(4-N-octylphenyl)ethyl]propane-1,3-diol Hydrochloride; 2-Amino-2-[2-(4-octyl-phenyl)-ethyl]-propane -1,3-diol hydrochloride; 2-Amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1,3-diol hydrochloride
CAS No.:
162359-56-0
Compound CID:
107969
Formula:
C19H34ClNO2
Formula Weight:
343.93
Specification
Relative Density:
1.016 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Fingolimod hydrochloride plays a role in relapsing multiple sclerosis and obesity research.
Library Information
Targets:
TRP/TRPV channel; S1P receptor; PAK; LPL receptor
Receptors:
TRPM7
Pathways:
GPCR/G protein; Membrane transporter/Ion channel; Cytoskeletal signaling
Plate Number:
AOCL-2
Plate Location:
a4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 145.38 mM
Water Max Solubility:
34.4 mg/mL; 100 mM
